Full background report

Sanja Miskovic

Chief Technical Advisor

Career chronology

Dates not established: University of British Columbia — Academic appointment in mining engineering. Sanja Miskovic academic biography (academic biography)
Concurrent as of 10 September 2026; start not established: Novex LLC — Chief Technology Officer. Appointment of Sanja Miskovic as Chief Technical Advisor (concurrent Novex CTO)
From 10 September 2026: American Rare Earths — Chief Technical Advisor. Appointment of Sanja Miskovic as Chief Technical Advisor (effective date)

Education and qualifications

Minerals engineering education

2011 and later · documented · medium materiality

ARR reports a 2011 minerals-engineering PhD from Virginia Tech and earlier University of Novi Sad degrees; UBC’s academic profile independently repeats these qualifications and describes her research and prior University of Utah faculty service.

Attribution: Responsibility not applicable. UBC profile corroborates claimed education; an official degree transcript was not reviewed.

Relevance: Technical training is relevant to her advisory work.

Appointment of Sanja Miskovic as Chief Technical Advisor (education and academic role); Sanja Miskovic academic biography (biography and education)

Suitability for the current role

Technical adviser and Novex role

2026 · analyst inference · high materiality

ARR appointed Dr Sanja Miskovic chief technical adviser effective 10 September 2026 to guide beneficiation, recovery and process scale-up. ARR also says she is CTO of its downstream partner Novex; her advisory appointment does not establish executive employment.

Attribution: Responsibility not applicable. Issuer appointment and concurrent technology-partner role are disclosed; decision authority and commercial arrangements are not independently established.

Relevance: Relevant to rare-earth separation and potential conflicts between ARR and a commercial partner.

Appointment of Sanja Miskovic as Chief Technical Advisor (appointment, role and Novex position)

Evidence gaps

Novex contractual economics and adviser decision rights are not established in the reviewed disclosure.
Independent transcript and comprehensive regulator, litigation and patent-ownership records were not reviewed.